The company’s main The opening price of Saifen Technology (688758.SH) on the first day of listing was 28.15 yuan,
up 551.62% at the opening. As of the morning closing, the increase narrow to 377.3%, with a market
value of 8.587 billion yuan. The company’s issue price this time is 4.32 yuan per share, and the issue
priceearnings ratio is 39.09 times, which is higher moldova email list 100000 contact leads than the industry’s average static priceearnings
ratio of 22.80 times in the last month, and lower than the average static priceearnings ratio of 52.43 times of comparable companies in the same industry.
Saifen Technology was found in 2009 and is headquarter in Suzhou. Since its establishment,
the company has independently develop analytical chromatographic column products with different separation modes. It has a complete range of products and a wide range of applications.
Currently, there are more than 1,000 subdivid products
Currently, the company’s main products can be divid into two major areas according to their
applications: analytical chromatography and industrial purification. The company provides
biopharmaceutical companies with separation and purification products and relat services for the
entire cycle and process from drug research and development, preclinical (PreIND) to clinical phases I,
II, III, production and quality control.
In terms of financial data, in 2021, 2022, 2023 conduct banklink gap analysis and JanuaryJune 2024 (referr to as the “reporting
period”), the company’s revenue was approximately RMB 155 million, RMB 213 million, RMB 245
million and RMB 152 million, respectively; the net profit attributable to the parent was RMB 20.7738
million, RMB 47.1393 million, RMB 52.4857 million and RMB 38.0793 million, respectively.
During the reporting period
The company’s main business gross profit margin was 71.08%, 76.30%, 71.14% and 74.40% respectively. In 2023, the main business gross profit philippines numbers margin declin as the new product technology is
still in the gradual stabilization stage.
Saifen Technology stat in its prospectus that the company plans to raise 800 million yuan, which will
be us for 200,000 litersyear of auxiliary materials for biopharmaceutical separation and purification,
research and development center construction projects, and to supplement working capital The company’s main.